tiprankstipranks
Trending News
More News >
Nuo Therapeutics (AURX)
OTHER OTC:AURX
US Market
Advertisement

Nuo Therapeutics (AURX) Technical Analysis

Compare
12 Followers

Technical Sentiment

Overall Consensus
Strong Buy
17Bullish
5Neutral
0Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Nuo Therapeutics’s (AURX) Moving Averages Convergence Divergence (MACD) indicator is 0.15, suggesting Nuo Therapeutics is a Buy.
Nuo Therapeutics’s (AURX) 20-Day exponential moving average is 2.27, while Nuo Therapeutics’s (AURX) share price is $2.5, making it a Buy.
Nuo Therapeutics’s (AURX) 50-Day exponential moving average is 2.02, while Nuo Therapeutics’s (AURX) share price is $2.5, making it a Buy.

Nuo Therapeutics (AURX) Pivot Points

Oct 20, 2025, 11:14 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.29
2.33
2.41
2.46
2.54
2.59
2.67
Fibonacci
2.33
2.38
2.41
2.46
2.51
2.54
2.59
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Nuo Therapeutics (AURX) Moving Averages

Oct 20, 2025, 11:14 AM
Period
Simple
Exponential
MA5
2.36Buy
2.42Buy
MA10
2.44Buy
2.38Buy
MA20
2.26Buy
2.27Buy
MA50
1.93Buy
2.02Buy
MA100
1.73Buy
1.82Buy
MA200
1.58Buy
1.60Buy
Nuo Therapeutics’s (AURX) 10-Day exponential moving average is 2.38, while Nuo Therapeutics’s (AURX) share price is $2.5, making it a Buy.
Nuo Therapeutics’s (AURX) 100-Day exponential moving average is 1.82, while Nuo Therapeutics’s (AURX) share price is $2.5, making it a Buy.
Nuo Therapeutics’s (AURX) stock price is $2.5 and Nuo Therapeutics’s (AURX) 50-day simple moving average is 1.93, creating a Buy signal.
Nuo Therapeutics’s (AURX) stock price is $2.5 and Nuo Therapeutics’s (AURX) 100-day simple moving average is 1.73, creating a Buy signal.
Nuo Therapeutics’s (AURX) stock price is $2.5 and Nuo Therapeutics’s (AURX) 200-day simple moving average is 1.58, creating a Buy signal.

Nuo Therapeutics (AURX) Technical Indicators

Oct 20, 2025, 11:14 AM
Name
Value
Implied Action
RSI (14)
59.16
Neutral
STOCH (9,6)
39.54
Neutral
STOCHRSI (14)
43.19
Neutral
MACD (12,26)
0.15
Buy
ADX (14)
21.18
Neutral
Williams %R
-57.03
Buy
CCI (14)
59.16
Neutral
ATR (14)
0.21
-
Ultimate Oscillator
70.00
Buy
ROC
28.87
Buy
Nuo Therapeutics’s (AURX) Relative Strength Index (RSI) is 59.16, creating a Neutral signal.
Nuo Therapeutics’s (AURX) Trend Strength Indicator (ADX) is 21.18, creating a Neutral signal.
Nuo Therapeutics’s (AURX) Commodity Channel Index (CCI) is 59.16, creating a Neutral signal.
Nuo Therapeutics’s (AURX) Price Rate of Change (ROC) is 28.87, creating a Buy signal.

FAQ

Is AURX a Buy, Hold, or Sell?
Based on AURX’s technical indicators, AURX is a Strong Buy.
    What is AURX’s RSI (14)?
    AURX’s RSI (14) is 59.16, which suggests AURX is a Neutral.
      What is AURX’s MACD?
      AURX’s MACD is 0.15, which suggests AURX is a Buy.
        What is AURX’s 5-day moving average?
        AURX’s 5-day moving average is 2.36, which suggests AURX is a Buy.
          What is AURX’s 20-day moving average?
          AURX 20-day moving average is 2.26, which suggests AURX is a Buy.
            What is AURX’s 50-day moving average?
            AURX’s 50-day moving average is 1.93, which suggests AURX is a Buy.
              What is AURX’s 200-day moving average?
              AURX’s 200-day moving average is 1.58, which suggests AURX is a Buy.
                What is AURX’s Williams % R (14)?
                AURX’s Williams % R (14) is -57.03, which suggests AURX is a Buy.
                  What is AURX’s CCI (14)?
                  AURX’s CCI (14) is 59.16, which suggests AURX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis